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ABSTRACT
Cellular senescence is the ultimate and irreversible
loss of replicative capacity occurring in primary
somatic cell culture. It is triggered as a stereotypic
response to unrepaired nuclear DNA damage or to
uncapped telomeres. In addition to a direct role of
nuclear DNA double-strand breaks as inducer of a
DNA damage response, two more subtle types of
DNA damage induced by physiological levels of
reactive oxygen species (ROS) can have a signifi-
cant impact on cellular senescence: Firstly, it has
been established that telomere shortening, which is
the major contributor to telomere uncapping, is
stress dependent and largely caused by a telomere-
specific DNA single-strand break repair inefficiency.
Secondly, mitochondrial DNA (mtDNA) damage is
closely interrelated with mitochondrial ROS produc-
tion, and this might also play a causal role for
cellular senescence. Improvement of mitochondrial
function results in less telomeric damage and slower
telomere shortening, while telomere-dependent
growth arrest is associated with increased mito-
chondrial dysfunction. Moreover, telomerase, the
enzyme complex that is known to re-elongate
shortened telomeres, also appears to have functions
independent of telomeres that protect against
oxidative stress. Together, these data suggest a
self-amplifying cycle between mitochondrial and
telomeric DNA damage during cellular senescence.
INTRODUCTION
Cellular senescence is the ultimate and irreversible loss
of replicative capacity occurring in primary somatic cell
culture. The discovery of replicative senescence had
profound influences not only with respect to the way
that ageing is studied, but also how ageing is perceived.
Initially, it was thought that cells once removed from an
organism would be able to replicate indefinitely, mainly as
a consequence of a long-held claim by Alexei Carrel that
chicken embryonic fibroblast cultures could be kept in
culture indefinitely (1). These findings lead to a widespread
notion that ageing was not a consequence of an intrinsic
cellular process but some characteristic inherent to the
existence of cells in a ‘body environment’. In this context,
it is easily understandable how Hayflick’s finding of a
finite lifespan of human fibroblasts had tremendous
impact on our current perception of ageing. He found
that embryo-derived fibroblasts can divide 50 10 times
before arresting irreversibly (2). This finding suggested
that an intrinsic molecular process must account for this
phenomenon.
Since then, a thorough characterisation of the various
phenotypic changes occurring with senescence had been
conducted by various laboratories in the 1970s and 1980s,
but none could give unequivocal clues as to the mechan-
ism or mechanisms behind it (3) until it was suggested that
the shortening of telomeres, the ends of chromosomes,
could function as a replicometer (counting the finite
number of cell divisions) and as a trigger of replicative
senescence in normal diploid cells (4,5). It was the Russian
biologist Alexei Olovnikov who in the late 1960s, after
learning about Hayflicks’ discovery, first predicted the
shortening of telomeres as an explanation for finite cell
division in cells grown in culture (6). This is still one of the
most amazing examples of scientific foresight, since it took
more than 20 years to show experimentally that the
amount of telomeric DNA does decline with ageing of
human fibroblasts (7). Of course, it was quite possible that
this was a mere marker of senescence like many others
that had been observed and no evidence of causality had
been demonstrated. Later, this question was answered by
showing that ectopic expression of the catalytic subunit of
telomerase, an enzyme able to counteract telomere
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shortening, can overcome senescence and lead to cell
immortalization on its own (8).
Telomere shortening was proposed as a counting mecha-
nism, which could explain two distinct observations,
namely the reproducibility of the ‘Hayflick limit’ and the
fact that cells frozen at a certain population doubling level
(PDL) would retain a memory of their PDL and, when
thawed, undergo the expected maximum number of divi-
sions (9). This was suggestive that a biological programme
of ageing was at hand. The alternative interpretation is that
telomere loss is merely a consequence of the cell’s inability
to synthesise new telomere sequences, and as such, a failure
to mobilise resources for maintenance. As predicted by
evolutionary theories of ageing, telomere shortening can
thus be seen as an example of limited investment in long-
term somatic maintenance and repair function (10). There
are good reasons why telomere shortening is unlikely to be
a counting mechanism. One is the observation that indi-
vidual cells from clonally derived populations show
heterogeneous division potential (11) and large hetero-
geneity in telomere length both between chromosome ends
within individual cells and between cells (12–14).
Moreover, it has been shown that the fraction of senescent
cells present in a mass population increases progressively
with population doublings, using BrdU labelling (15),
Ki67 staining (16), p53-reporter assay (17) and staining
for g-H2AX, a marker for senescence-associated DNA
damage foci (18). These senescent cells in ‘young’ cultures
showed characteristics of mitochondrial dysfunction
including high levels of reactive oxygen species (ROS)
together with short telomeres and activation of telomere-
induced DNA damage signalling (19–21). This indicates
that the ‘Hayflick limit’ can only be applied to mass
populations of cells, and that the lifespan of an individual
cell lineage is not controlled by a defined genetic
programme, but governed by stochastic factors upstream
of telomere shortening, probably related to oxidative
stress. Therefore, we will now examine in detail how
oxidative stress does affect telomeres specifically and which
role mitochondria play in this process. We will also review
the evidence suggesting a role for mitochondria, in
particular mitochondrial DNA, in the process of cellular
senescence.
TELOMERE ATTRITION IS DEPENDENT ON
MITOCHONDRIAL FUNCTION
The minimal rate of telomere shortening predicted from
the end replication problem is 3 bp/end/cell division (22),
however, human cells lacking telomerase lose on average
50–300 bp/end/cell division. How can this be explained?
There is good evidence, both in Saccharomyces cerevisiae
and in human cells (23–26) that telomere ends are
processed by multiple nucleases to generate protruding
30 ends as part of telomere structure. To what extent this
end processing actually contributes to telomere shortening
is less clear. The simplest idea of a direct correlation
between overhang length and telomere shortening rate has
been refused experimentally. A study involving fibroblast
strains from 21 donors with 2 orders of magnitude of
variation in telomere shortening rate failed to show any
correlation between telomere overhang length and short-
ening rate, suggesting that overhang length does not
correlate with telomere shortening (27).
Oxidative stress is another factor that contributes to
telomere attrition (28). In normal cell culture conditions,
cells are exposed to above-physiological levels of oxygen.
While oxygen pressure in the environment is 137mmHg
(corresponding to 21% oxygen at sea level), cells in an
organism are exposed to an oxygen partial pressure
typically between 3 and 7%. Moreover, it has been
demonstrated that oxygen pressure has a significant
impact on the cells’ replicative lifespan. Packer and
Fuehr have shown that the replicative lifespan of human
diploid cells can be extended by growing them in low
oxygen (29). Also, by growing telomerase-positive mice
embryonic fibroblasts at 3% oxygen for at least 60 days
(30), it has been shown that telomere-independent sene-
scence at the level of a whole culture can be significantly
postponed by lowering oxidative stress. However, these
experiments do not exclude the possibility that individual
mouse cells grown under physiological oxygen may accu-
mulate sufficient DNA damage to become arrested (31).
Oxidative stress can induce various types of DNA
damage, including oxidized bases, single- and double-
strand breaks (SSBs and DSBs). DSBs trigger a DNA
damage response that, if persistent, can activate senes-
cence via the p53 and p21 tumour suppressors. This
pathway has been well characterized (32). ATM and ATR
are recruited to the site of damage and are activated,
leading to phosphorylation of the tail of a histone protein
variant called ‘H2A.X’ adjacent to the site of DNA
damage. It is thought that this phosphorylation of histone
H2A.X facilitates the focal assembly of checkpoint and
DNA repair factors including 53BP1, MDC1/NFBD1 and
Nbs1, and also promotes the activation by phosphoryla-
tion of Chk1 and Chk2, which converge the signal on p53.
This response occurs when non-telomeric DNA damage is
generated by various agents like oxidative stress and
ionizing radiation and can lead to induction of a senescent
phenotype (33–35).
Telomeres are normally in a ‘capped’ state, i.e.
unrecognizable to DNA damage response and repair
enzyme complexes (36). Structurally, they form terminal
loops, which are stabilised by a number of telomere
binding proteins. Two of these proteins bind to double-
stranded telomeric DNA (TRF1 and -2) and POT-1 binds
to single-stranded telomeric DNA. This complex of
proteins has been called ‘shelterin’, since it ‘shelters’ i.e.
protects chromosome ends (37). It is believed that
telomere shortening destabilizes telomeric loops (38) and
as a consequence increases the probability of telomere
uncapping. Few years ago, it was shown that uncapping of
telomeres, whether by inhibition of TRF2 or telomere
shortening, activates the same DNA damage response as
do DSBs (18,39) (Figure 1).
Thus, cellular senescence can be induced as a response
to either persistent DSB (telomere-independent or stress-
induced premature senescence) or uncapped telomeres
(replicative senescence). Telomere-dependent, replicative
senescence is not stress independent, however.
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The intensity and dosage of oxidative stress determine the
probability of DSB generation. Intense, acute stress will
generate DSBs at higher frequency and might modify
these broken DNA ends to make them more resistant to
repair, leading to DSB persistence and so induction of
senescence via non-telomeric DNA damage response.
Chronic oxidative stress of low intensity mainly generates
oxidative base modifications and base excision repair
intermediates, i.e. abasic sites and SSBs.
Telomeres acquire such oxidative single-strand damage
faster than the bulk of the genome for two reasons: First,
sequences containing guanine triplets are exquisitely
sensitive to oxidative modification (40,41). For instance,
a human telomere sequence inserted in a plasmid showed
up to 7-fold more strand breakage than a control sequence
(41). Second, repair of SSB (42), and to some extent also
of UV-induced damage (43), is significantly less efficient in
telomeres as compared to the bulk of the genome. This
holds true even for a comparison between telomeres and
interstitial guanine-rich repetitive sequence tracts (42).
The cause for this telomere-specific repair deficiency has
not been established with certainty yet. However,
a structural basis for it is probable, since TRF2 binds
to telomeric double-stranded DNA, stabilizes the telo-
meric loop and thus contributes to telomere capping.
Overexpression of TRF2 decreases the telomere length
threshold at which replicative senescence is signalled in
accordance with improved capping (44). However, it also
accelerates the rate of telomere shortening (44) and further
decreases the efficiency of SSB repair specifically in
telomeres (45). The most simplistic interpretation of
these data is that telomere capping would be detrimental
to free access of DNA repair complexes to telomeres.
It has been shown that TRF2 (and TRF1) binding can
stall the replication fork progression at telomeres (46).
However, it needs to be mentioned that TRF2 plays more
complex roles at telomeres as it interacts with and inhibits
enzymes involved in DNA repair including ATM (47)
and Polymerase b (48), while its binding to telomeres is
reduced by oxidative DNA damage (49).
Irrespective of the specific mechanism causing repair
inefficiency, telomeres enter DNA replication with higher
frequencies of single-strand DNA damage than all the
bulk of the genome. This contributes significantly to
telomere shortening (50), with the frequency of single-
strand damage directly correlated with the amount of
telomere loss (51). Oxidative damage-dependent telomere
shortening might be caused by a temporal stalling of
the replication fork or might be recombination dependent
(52). It might be a significant cause of telomere length
heterogeneity between different chromosomes and between
the same chromosomes in different clonally derived cells
(12,19).
Finally, oxidative stress interferes with telomere
maintenance also via its effect on telomerase activity.
Telomerase is a ribonucleoprotein complex that consists
of two main components – the RNA component (TER),
containing the antisense template sequence for telomere
synthesis and the catalytic protein, telomerase reverse
transcriptase –(TERT). Telomerase re-elongates telomeres
in a highly regulated fashion to counteract telomere
shortening. This is sufficient to confer extended lifespan
and often immortality to cells that would otherwise
senesce due to continuous telomere shortening (8).
Physiologically, human telomerase is expressed in germ
line and stem cells and in most cancers, but its expression
is low (haematopoetic cells and endothelial cells) or
undetectable without sophisticated enrichment protocols
(53) in somatic human cells like fibroblasts. Oxidative
stress diminished telomerase activity in endothelial cells
(54–56), vascular smooth muscle cells (57) or leukemic
cancer cell lines (58) together with an acceleration of
telomere attrition. However, oxidative stress had no effect
on telomerase activity in fibroblasts overexpressing TERT
ectopically (19), suggesting preferentially transcriptional
regulation.
Two properties of oxidative stress-dependent telomere
attrition are important. First, it is dependent on DNA
replication. The probability of generating DSBs directly at
a frequency high enough to result in a measurable
telomere loss without DNA replication is negligible for
physiologically and pathologically obtainable stress levels.
Second, oxidative damage can be a major, and often
actually the main, contributor to telomere loss in cell
culture under standard conditions. This is shown by the
fact that telomere shortening rates in cultured human
fibroblasts not only accelerate if oxidative stress is
increased, but that they can be diminished if oxidative
stress levels are reduced below those in standard condi-
tions by using free radical scavengers (59), enzymatic (60)
or non-enzymatic (61) antioxidants or low ambient
oxygen concentrations (62,63), in some cases to levels
similar to the minimal values predicted by the end
replication problem alone. For instance, we measured
telomere shortening rates of 7 9 bp/PD in BJ fibroblasts,
a strain with very high antioxidant capacity (28,60),
and of 9 29 bp/PD in MRC5 fibroblasts treated with
Dinitrophenol, an agent that reduces mitochondrial ROS
generation by mild uncoupling (20)
Now, the important question is: Is oxidative stress-
dependent telomere length regulation merely a response to
more or less artificial changes in cell culture environments
(i.e. a ‘cell culture artefact’)? or is it part of an intrinsic
mechanism governing the ageing process? Correlative
evidence from human population studies collectively
suggests an association of short telomeres with conditions
of increased oxidative stress, including smoking, obesity,
various cardiovascular diseases, psychological and socio-
economic stress (64–66). Cells in telomere-dependent sene-
scence accumulate in aging baboon skin (67,68). We
propose mitochondrial dysfunction as a major mechanistic
link between stress-dependent and telomere-dependent
physiological ageing processes in cells. Mitochondria are
the major source of oxygen-free radicals in cells. It
has been revealed that mitochondrial function changes as
cells reach the end of their replicative lifespan, leading
to increased generation of ROS and metabolic ineffi-
ciency (20,69–72). Increased ROS leads to accumulation of
oxidation products, such as protein carbonyls and
lipofuscin, which have been shown to occur in senescent
fibroblasts (73,74).
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In addition to correlative evidence showing mitochon-
drial dysfunction in telomere-dependent senescence,
there is also good evidence supporting a causal role
for mitochondrial dysfunction in the process. Selective
targeting of antioxidants directly to the mitochondria has
been shown to counteract telomere shortening and
increase lifespan in fibroblasts under mild oxidative
stress (61). Continuous treatment with nicotinamide,
which affects mitochondrial function and ROS generation,
has been reported to extend lifespan (an amazing
1.6-fold increase) and decelerate telomere shortening
(75). Also, mild chronic uncoupling of mitochondria
that reduced the production of superoxide anion,
improved telomere maintenance and extended telomere-
dependent lifespan (20).
On the other hand, mitochondrial dysfunction gener-
ated by severe mitochondrial depolarization using an
uncoupling agent FCCP led to an increased production
of ROS, telomere loss and chromosome fusions in mouse
embryos (76). Moreover, Oexle and Zwirner showed that
patients with mitochondrial diseases MELAS and LHON
had, on average, 1.5 kb shorter telomeres in white blood
cells than those of age-matched controls (77).
This set of data is suggestive of a novel role for
telomeres as sensors of mitochondrial function in a cell
(78). When mitochondrial dysfunction occurs, with con-
comitant increased ROS generation, the specific suscept-
ibility of telomeres to oxidative damage (42) leads to
accelerated telomere shortening, increased probability of
uncapping, activation of a DNA damage response and
finally irreversible cell cycle arrest (Figure 1). Thus, as
previously suggested, the replicative lifespan of a cell
could be determined by a network of processes involving
mitochondrial dysfunction, oxidative stress and telomere
shortening (20,78,79).
However, one important question remains: What is
the cause of mitochondrial dysfunction and ROS genera-
tion? Is it dependent on damage to the mitochondrial
genome?
MTDNA DAMAGE AND SENESCENCE: IS THERE
A LINK?
Mitochondrial DNA has for a long time been implicated
in the ageing process. The idea was first proposed by
Harman, who predicted the involvement of free radicals in
the ageing process (80,81). The concept was that the close
proximity between the sites of ROS production and the
mtDNA would render the latter more susceptible to
damage than the nuclear genome, and lead to defects in
mitochondrial metabolism. The long-held view that the
mitochondrial genome is not protected by histones and
mtDNA repair is inefficient has been challenged in recent
years by showing that TFAM acts like a histone covering
mtDNA (82) and that there exist functional repair
mechanisms for different types of DNA damage within
mitochondria with the possible exception of nucleotide
excision repair (83). Even so, it has been shown that
mtDNA damage is more extensive and persistent than
nuclear DNA damage in cultured human fibroblasts
following treatment with hydrogen peroxide (84) and
this correlates with functional impairment in mitochon-
dria (85). Treatment of normal human fibroblasts with
sublethal levels of oxidative stress has also been associated
with accumulation of the mtDNA common deletion, a
specific 4977 bp deletion often found in mtDNA (33).
An age-dependent increase of mtDNA mutation
frequency was first observed in post-mitotic cells such as
neurons and muscle cells (86–89), but has since been
described in highly proliferative cells such as the epithelial
stem cells of the gut wall as well (90). mtDNA mutations
are responsible for deficient activity of respiratory chain
enzymes such as Cytochrome C oxidase, which is a
mitochondrial membrane–bound enzyme composed of
subunits that are encoded in both the mitochondria (COX
subunits I, II and III) and the nucleus (all others). The
frequency of COX-deficient human heart muscle cells was
shown to increase significantly with age, but remained
always below 1% (88). In situ hybridization studies using
mtDNA probes showed accumulation of mtDNA dele-
tions in COX negative cells (91). Using microdissection to
isolate muscle fibres, it was shown that all electron
transport chain–deficient fibres in rat skeletal muscle
contained mtDNA deletion mutations (92,93). In single
neurons from substantia nigra of humans showing COX
deficiency, an age-dependent increase in mtDNA deletions
was found in two independent studies (94,95).
Consequently, an attractive hypothesis is that the
increase of mutational load in mtDNA with age con-
tributes causally to mitochondrial dysfunction and
increased ROS production, so creating a circulus vitiosus.
However, new data question the causal link between
mtDNA mutations and ROS generation. Homozygous
knock-in mice expressing a proof reading–deficient
version of the nucleus-encoded catalytic subunit of
Figure 1. Telomeres shorten with cell division due to the
‘end-replication problem’ and single-strand break accumulation due
to damage by ROS generated as by-product of mitochondrial
respiration. This induces a DNA damage response including formation
of telomeric DNA damage foci and activation of p53. Activated p53
triggers senescent growth arrest.
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mtDNA polymerase g (PolgA) have been generated that
showed an extremely high level of mtDNA mutations and
deletions and a significant decrease in lifespan (96).
However, even though mitochondrial function was
affected, no evidence for increased oxidative stress was
found in these animals (97,98). Most strikingly, mice that
are heterozygous for PolgA function showed no significant
reduction in lifespan despite a mtDNA point mutation
burden 30 times higher than in old wild-type animals (99).
These studies suggested that mtDNA point mutation load
does not limit lifespan of wild-type mice and that mtDNA
point mutations, even at very high levels, do not neces-
sarily lead to increased mitochondrial ROS generation.
It remains to be seen whether there is a more sinister role
for mtDNA deletions in aging.
So far, there is very little data to assess the role, if any,
of mtDNA mutations in cellular replicative senescence.
Accumulation of mtDNA point mutations in fibroblasts
isolated from old individuals has been reported (100).
Most strikingly, a T414G transversion was found in a high
proportion (up to 50%) of mtDNA molecules from
individuals above 65 years of age. However, when several
fibroblasts populations carrying the heteroplasmic T414G
mutation were grown in vitro, outgrowth of the mutant
cells by wild-type cells was observed (101). This led to the
suggestion that accumulation of mtDNA point mutations
is a phenomenon occurring exclusively in vivo.
Using a real-time PCR-based method (102), we have
recently found evidence of increased mtDNA damage in
senescent human fibroblasts (20). However, these are
correlative data and it is not possible to discern whether
mtDNA damage caused mitochondrial dysfunction or was
a consequence of it. It could well be that other factors
besides mtDNA damage and/or mutation might be more
important for the generation of ROS. Such factors could
include the regulation of mitochondrial turnover or
mitochondrial fusion and fission (Figure 2) in addition
to extra-mitochondrial ones.
Accordingly, a recent study has shown that mitochon-
drial elongation by knock down of the mitochondrial
fission protein hFis1 led to induction of senescence,
possibly through increased ROS generation and activation
of a DNA damage response (103). Moreover, there is
some evidence suggesting that mitochondrial ROS gen-
eration in senescence might be due to increased mitochon-
drial density, which can occur as a consequence of
mitochondrial dysfunction (20,104). In fact, it has been
shown that overexpression of PGC-1a, the master
regulator of mitochondrial biogenesis, leads to induction
of senescence in human fibroblasts (105). The association
between increased mitochondrial density and ROS gen-
eration might be due to amplification of damaged mtDNA
molecules. In summary, the role of mtDNA damage and
mutation in senescence is still unclear.
Telomerase and oxidative stress: a role beyond telomeres
In recent years, indications for additional functions of
telomerase independent of telomere maintenance are
accumulating. If telomerase is inhibited in tumour cells,
there is either a delayed response that depends on telomere
shortening or a rapid effect on cell viability without any
measurable effect on telomere length (106–110). These
data suggest that telomerase promotes cell survival and
stress resistance by mechanisms that appear to be largely
independent on telomere length maintenance. Zhang et al.
and Fu et al. (111,112) showed an increased resistance of
hTERT overexpressing cells to apoptotic stimuli at an
early, premitochondrial step. Sharma et al. (113) found an
increased repair capacity of hTERT overexpressing cells.
We and others demonstrated an enhanced sensitivity of
tumour cells to certain DNA damaging agents when
telomerase was impaired (107,113–117). We showed that
overexpression of TERT conferred increased stress
resistance, improved antioxidant defence and differentia-
tion capacity to mouse embryonic stem cells (118).
Ectopic hTERT expression in normal cells as well as
hTERT inhibition/depletion in telomerase positive cancer
cells and even in yeast S. cerevisiae caused significant
changes to the transcriptome and global gene expression
patterns (106,108,119,120) that are largely unrelated to
telomere maintenance. Interestingly, among a wide range
of functional classes, large groups of genes with functions
in metabolism, specifically mitochondrial metabolism,
have repeatedly been reported to appear dependent of
telomerase (106,119). Bagheri et al. (106) found that
telomerase modulated glucose consumption and appeared
to control the glycolytic pathway in tumour cells, thereby
potentially altering the energy state. Recently, telomerase
has been added to a growing list of proteins, such as p53,
HMGA1, VHL, APP, prohibitins, Lon-protease, etc., that
can shuttle between the nucleus and the different sub-
cellular compartments including mitochondria. Impor-
tantly, it has been shown that telomerase that normally is
Figure 2. Possible mechanisms influencing mitochondrial ROS genera-
tion: (1) mtDNA damage could lead to dysfunctional respiratory chain
activity and increased ROS, (2) mitochondrial elongation by decreased
fission has been shown to increase ROS generation, (3) increased
mitochondrial biogenesis has been shown to correlate with ROS
generation and induce cellular senescence. ROS-generated telomere
shortening as well as double-stranded breaks at non-telomeric DNA
activate a DNA damage response and cellular senescence.
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located in the nucleus can shuttle to cytoplasm and/or
mitochondria upon oxidative challenge (55,121–123).
Santos et al. (117) described a specific mitochondrial
import sequence at the N-terminus of hTERT. Oxidative
stress activates nuclear export and mitochondrial import
for both ectopically expressed and endogenous telomerase
(55,121–123). Haendeler et al. (55) found that nuclear
export of telomerase occurs during in vitro senescence of
human endothelial cells and can be delayed by treatment
with antioxidants. One possible mechanism connecting
oxidative stress and nuclear exclusion of telomerase is the
activation of Src kinases by ROS (124). It has been shown
that phosphorylation of tyrosine 707 by Src kinase is
necessary for nuclear exclusion of hTERT following
oxidative stress (121). A similar process has been described
for T-lymphocytes where telomerase function is regulated
via phosphorylation and nuclear translocation (125).
These data suggest that subcellular shuttling is not an
artefact of ectopic hTERT expression. Rather, transport
of hTERT to mitochondria is a directed, naturally
occurring process that is regulated by either exogeneously
or endogenously generated oxidative stress.
The biological significance of the translocation of
hTERT into mitochondria under oxidative stress is still
elusive. Santos et al. (122,123) found that ectopic over-
expression of hTERT led to higher levels of mtDNA
damage under acute oxidative stress. In contrast, there is
an increasing number of papers showing the telomerase
protects mitochondrial function and displays an anti-
apoptotic function. Massard et al. (109) characterised
hTERT as an endogenous inhibitor of mitochondrial
apoptosis induced by different agents including oxidative
stress in cancer cells. Neurons with decreased hTERT
levels exhibited increased levels of oxidative stress and
mitochondrial dysfunction after exposure to amyloid beta,
whereas overexpression of hTERT in the same system led
to an improved mitochondrial function and a decreased
oxidative stress level (126). Kang et al. (127) found that
after ischemic brain injury TERT is induced in postmitotic
neurons in TERT transgenic mice and prevents NMDA
neurotoxicity via shifts of free cytosolic free Ca2+ to the
mitochondria. The authors found an enhanced basal level
of mitochondrial membrane potential and a higher Ca2+
storage capacity of the mitochondria due to TERT
overexpression. Our own data indicate protection of
mtDNA and mitochondrial function under oxidative
stress by ectopically expressed hTERT (unpublished).
These results show that there is an interaction between
mitochondrially localised hTERT and mitochondrial
function that seems to be complex and can involve differ-
ent physiological and signalling pathways. It is not yet
clear whether mitochondrial localisation of hTERT is
necessary to improve mitochondrial function and/or to
protect cells from stress-induced apoptosis.
CONCLUSIONS
It appears highly probable that damage to two specific
subsets of cellular DNA, namely telomeres and mtDNA,
plays an important role in cellular senescence. These two
types of DNA damage are functionally interrelated at
various levels. mtDNA damage, especially deletions,
might contribute to mitochondrial dysfunction and ensu-
ing ROS production, which is a major causal factor for
telomere damage and shortening, resulting eventually in
senescence signalling. Conversely telomerase, the central
enzyme in telomere length maintenance, can translocate to
mitochondria under stress and impacts on mtDNA
protection and mitochondrial function. It is possible that
there is a self-amplifying cycle between mitochondrial and
telomeric DNA damage driving cellular senescence.
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